Literature DB >> 2043639

Activating region of HIV-1 Tat protein: vacuum UV circular dichroism and energy minimization.

E P Loret1, E Vives, P S Ho, H Rochat, J Van Rietschoten, W C Johnson.   

Abstract

Tat protein is a trans-acting transcriptional activator of the human immunodeficiency virus type 1 and is essential for viral transcription. By homology with other transcriptional activators, Tat is expected to possess a nucleic acid binding region and a separate adjacent activating region. In order to localize the activating region of Tat, we have synthesized the sequences 2-23 and 38-60 of the protein. These two peptides contain the two candidates for the activating regions proposed from mutation experiments in previous studies: sequence 1-13 and sequence 38-45. The argument advanced to justify the location of the activating region within the sequence 1-13 was the periodicity of acidic, polar, and hydrophobic residues consistent with that of an amphipathic alpha-helix, similar to the activating region of many eukaryotic transcriptional activators. We have monitored by vacuum UV circular dichroism the ability of each peptide to adopt an alpha-helical conformation under conditions that strongly favor the formation of secondary structures. Only peptide 38-60 adopts an alpha-helical conformation in these conditions, in keeping with Chou-Fasman prediction. Energy minimization and molecular dynamics were carried out for several possible conformations of sequences 1-14 and 38-60. Our results indicate that only the sequence 38-45 is able to form an alpha-helix with amphipathic characteristics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2043639     DOI: 10.1021/bi00238a027

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors.

Authors:  V P Torchilin; R Rammohan; V Weissig; T S Levchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator.

Authors:  E P Loret; P Georgel; W C Johnson; P S Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

3.  An 85-kilodalton herpes simplex virus type 1 alpha trans-induction factor (VP16)-VP13/14 fusion protein retains the transactivation and structural properties of the wild-type molecule during virus infection.

Authors:  J L McKnight; M Doerr; Y Zhang
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

4.  NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat.

Authors:  A Mujeeb; K Bishop; B M Peterlin; C Turck; T G Parslow; T L James
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

5.  Conformational analysis of the Campylobacter jejuni porin.

Authors:  J M Bolla; E Loret; M Zalewski; J M Pagés
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

6.  A peptide from autoantigen La blocks poliovirus and hepatitis C virus cap-independent translation and reveals a single tyrosine critical for La RNA binding and translation stimulation.

Authors:  Raquel E Izumi; Saumitra Das; Bhaswati Barat; Santanu Raychaudhuri; Asim Dasgupta
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 7.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors:  Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

8.  HIV-1 capsid assembly inhibitor (CAI) peptide: structural preferences and delivery into human embryonic lung cells and lymphocytes.

Authors:  Klaus Braun; Martin Frank; Rüdiger Pipkorn; Jennifer Reed; Herbert Spring; Jürgen Debus; Bernd Didinger; Claus-Wilhelm von der Lieth; Manfred Wiessler; Waldemar Waldeck
Journal:  Int J Med Sci       Date:  2008-07-31       Impact factor: 3.738

9.  High yields and soluble expression of superoxide dismutases in Escherichia coli due to the HIV-1 Tat peptide via increases in mRNA transcription.

Authors:  Yangdong Sun; Qiao Ye; Min Wu; Yonghong Wu; Chenggang Zhang; Weiqun Yan
Journal:  Exp Mol Med       Date:  2016-10-14       Impact factor: 8.718

10.  A novel CAV derived cell-penetrating peptide efficiently delivers exogenous molecules through caveolae-mediated endocytosis.

Authors:  Gaowei Hu; Wenlv Zheng; Ao Li; Yaru Mu; Mingyu Shi; Tuofan Li; Haitao Zou; Hongxia Shao; Aijian Qin; Jianqiang Ye
Journal:  Vet Res       Date:  2018-02-13       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.